OR WAIT null SECS
© 2021 MJH Life Sciences and Urology Times. All rights reserved.
© 2021 MJH Life Sciences™ and Urology Times. All rights reserved.
September 13, 2021
The mitomycin-containing reverse thermal gel UGN-101 (Jelmyto) produced durable responses in patients with low-grade upper tract urothelial carcinoma.
September 11, 2021
The prognostic factor analysis included patients who received either 177Lu-PSMA-617 or 177Lu-J591.
February 11, 2021
Determining the optimal treatment approach for patients with non–clear cell renal cell carcinoma has long been an unmet medical need in the field.
September 23, 2020
Pivotal phase 3 trial launched to confirm promising results in metastatic urothelial carcinoma.